共 50 条
- [31] The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV HIV CLINICAL TRIALS, 2012, 13 (01): : 33 - 45
- [34] Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection - Reply NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (11): : 1183 - 1183
- [35] Improved Treatment for Primary HIV Infection by Interferon-Alfa Therapy? Does HCV Treatment in HIV/HCV Coinfected Patients Help Us to Test This Hypothesis? JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (02): : 362 - 362
- [39] Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (06): : 1334 - 1335
- [40] Cryoglobulinemia-Related Vasculitis During Effective Anti-HCV Treatment with PEG-Interferon alfa-2b Infection, 2008, 36 : 285 - 287